These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 11490175)
1. Pharmacological characterization of the serotonin transporter in young and elderly subjects. Marazziti D; Baroni S; Rossi A; Masala I; Giannaccini G; Gori V; Lucacchini A; Cassano GB Neuropsychobiology; 2001; 44(2):78-83. PubMed ID: 11490175 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of the cloned human 5-hydroxytryptamine transporter. Agnel M; Esnaud H; Langer SZ; Graham D Biochem Pharmacol; 1996 May; 51(9):1145-51. PubMed ID: 8645336 [TBL] [Abstract][Full Text] [Related]
3. Distinct effects of imipramine on 5-hydroxytryptamine uptake mediated by the recombinant rat serotonin transporter SERT1. Sur C; Betz H; Schloss P J Neurochem; 1998 Jun; 70(6):2545-53. PubMed ID: 9603221 [TBL] [Abstract][Full Text] [Related]
4. The serotonin transporter from human brain: purification and partial characterization. Rotondo A; Giannaccini G; Betti L; Chiellini G; Marazziti D; Martin C; Lucacchini A; Cassano GB Neurochem Int; 1996 Mar; 28(3):299-307. PubMed ID: 8813248 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the platelet serotonin transporter by protein kinase C in the young and elderly. Marazziti D; Rossi A; Masala I; Rotondo A; Palego L; Mazzoni M; Giannaccini G; Lucacchini A; Cassano GB Biol Psychiatry; 1999 Feb; 45(4):443-7. PubMed ID: 10071715 [TBL] [Abstract][Full Text] [Related]
6. Presence and characterization of the serotonin transporter in human resting lymphocytes. Marazziti D; Rossi A; Giannaccini G; Baroni S; Lucacchini A; Cassano GB Neuropsychopharmacology; 1998 Aug; 19(2):154-9. PubMed ID: 9629569 [TBL] [Abstract][Full Text] [Related]
7. Increased density of the platelet serotonin transporter in autism. Marazziti D; Muratori F; Cesari A; Masala I; Baroni S; Giannaccini G; Dell'Osso L; Cosenza A; Pfanner P; Cassano GB Pharmacopsychiatry; 2000 Sep; 33(5):165-8. PubMed ID: 11071017 [TBL] [Abstract][Full Text] [Related]
8. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618 [TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939 [TBL] [Abstract][Full Text] [Related]
10. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants. Mortensen OV; Kristensen AS; Wiborg O J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251 [TBL] [Abstract][Full Text] [Related]
11. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers. Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403 [TBL] [Abstract][Full Text] [Related]
12. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain. Moreau X; Jeanningros R; Mazzola-Pomietto P Neuropsychopharmacology; 2001 Jun; 24(6):652-62. PubMed ID: 11331145 [TBL] [Abstract][Full Text] [Related]
13. Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55. Scheffel U; Kim S; Cline EJ; Kuhar MJ Synapse; 1994 Apr; 16(4):263-8. PubMed ID: 8059336 [TBL] [Abstract][Full Text] [Related]
14. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647 [TBL] [Abstract][Full Text] [Related]
15. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Owens MJ; Knight DL; Nemeroff CB Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737 [TBL] [Abstract][Full Text] [Related]
16. S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. Millan MJ; Dekeyne A; Papp M; La Rochelle CD; MacSweeny C; Peglion JL; Brocco M J Pharmacol Exp Ther; 2001 Aug; 298(2):581-91. PubMed ID: 11454919 [TBL] [Abstract][Full Text] [Related]
17. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985 [TBL] [Abstract][Full Text] [Related]
18. Decrease of serotonin transporters in blood platelets after epileptic seizures. Cupello A; Favale E; Audenino D; Scarrone S; Gastaldi S; Albano C Neurochem Res; 2005 Apr; 30(4):425-8. PubMed ID: 16076011 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter. Chudzik J; McCarthy D; Bakish D; Ravindran A; Hrdina PD Biochem Pharmacol; 1995 Oct; 50(8):1211-5. PubMed ID: 7488236 [TBL] [Abstract][Full Text] [Related]
20. High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions. Plenge P; Wiborg O Neurosci Lett; 2005 Aug; 383(3):203-8. PubMed ID: 15955412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]